MILÁN, 30 de mayo de 2024 /PRNewswire/ — NTC, compañía farmacéutica internacional con sede en Italia, con enfoque específico en oftalmología y con un importante portafolio también en ginecología y gastroenterología, continúa su camino de certificación y recibe la quinta aprobación del…
Month: May 2024
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, May 30, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. (“Biogen Inc.” or “the Company”) (NASDAQ: BIIB) and certain of its…
Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System
The collaboration between two Danish companies aims to revolutionize drug discovery with help from quantum computing, AI and computer-aided drug design. COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ — Tetra Pharm Technologies and Kvantify join forces in a strategic partnership to…
Tetra Pharm Technologies y Kvantify anuncian una alianza
– Tetra Pharm Technologies y Kvantify anuncian una alianza para acelerar el descubrimiento de nuevos fármacos dirigidos al sistema endocannabinoide – La colaboración entre dos empresas danesas pretende revolucionar el descubrimiento de fármacos con la ayuda de la informática cuántica, la…
Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System
The collaboration between two Danish companies aims to revolutionize drug discovery with help from quantum computing, AI and computer-aided drug design. COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ — Tetra Pharm Technologies and Kvantify join forces in a strategic partnership to…
Tetra Pharm Technologies und Kvantify geben Partnerschaft zur Beschleunigung der Entdeckung neuer Arzneimittelkandidaten bekannt, die auf das Endocannabinoid-System abzielen
Die Zusammenarbeit zwischen zwei dänischen Unternehmen zielt darauf ab, die Arzneimittelforschung mit Hilfe von Quantencomputing, KI und computergestütztem Wirkstoffdesign zu revolutionieren. KOPENHAGEN, Dänemark, 30. Mai 2024 /PRNewswire/ — Tetra Pharm Technologies und Kvantify…
NTC gives long term consistency to its ophtha portfolio with another MDR CE Certificate approval
MILAN, May 30, 2024 /PRNewswire/ — NTC, an International pharmaceutical company with headquarter in Italy, with a specific focus in ophthalmology and with a significant portfolio in gynecology and gastroenterology too, continues in its certification path and receives the fifth Medical…
Valmet enters joint venture with Körber to advance the digital offering to the tissue industry
Valmet Oyj press release, May 30, 2024, at 10:15 a.m. EEST ESPOO, Finland, May 30, 2024 /PRNewswire/ — Valmet and Körber have on May 29, 2024, reached a joint venture agreement to further strengthen FactoryPal, a venture of Körber. FactoryPal is a software developed for tissue converting…
Vesper Bio announces completion of single ascending dose stage in trial of its lead candidate VES001, a potentially disease-modifying treatment for fronto-temporal dementia
COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ — Vesper Bio ApS (“Vesper” or “the Company”), a clinical stage biotech and world leader in sortilin receptor biology, today announces completion of the single ascending dose stage of its first-in-human trial of VES001 in healthy volunteers….
Gaming Innovation Group launching new SweepX solution with leading U.S. partner
ST JULIANS, Malta, May 30, 2024 /PRNewswire/ — Gaming Innovation Group Inc. (GiG) has announced the launch of SweepX, a revolutionary social sweepstakes casino platform solution for the USA, with the release further bolstered by the announcement of a binding Head of Terms for a strategic…
